141 related articles for article (PubMed ID: 12596750)
1. Initial management of glycemia in type 2 diabetes.
Apolito RA
N Engl J Med; 2003 Feb; 348(8):760-1; author reply 760-1. PubMed ID: 12596750
[No Abstract] [Full Text] [Related]
2. Do thiazolidinediones cause congestive heart failure?
Kennedy FP
Mayo Clin Proc; 2003 Sep; 78(9):1076-7. PubMed ID: 12962160
[No Abstract] [Full Text] [Related]
3. Pioglitazone and rosiglitazone for diabetes.
Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy in type 2 diabetes: the role of repaglinide.
Moses R
J Assoc Physicians India; 2001 Jan; 49 Spec No():62-8. PubMed ID: 11235608
[No Abstract] [Full Text] [Related]
5. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.
Nesto RW; Bell D; Bonow RO; Fonseca V; Grundy SM; Horton ES; Le Winter M; Porte D; Semenkovich CF; Smith S; Young LH; Kahn R; ;
Circulation; 2003 Dec; 108(23):2941-8. PubMed ID: 14662691
[No Abstract] [Full Text] [Related]
6. [Tackling insulin resistance. Control of etiology in type 2 diabetes].
MMW Fortschr Med; 2000 May; 142(21):66-7. PubMed ID: 10872300
[No Abstract] [Full Text] [Related]
7. Thiazolidinediones for type 2 diabetes. All glitazones may exacerbate heart failure.
Benbow A; Stewart M; Yeoman G
BMJ; 2001 Jan; 322(7280):236. PubMed ID: 11159623
[No Abstract] [Full Text] [Related]
8. [Rosiglitazone: clinical data].
Blickle JF
Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S27-33. PubMed ID: 12037505
[No Abstract] [Full Text] [Related]
9. Why I initiate therapy with two insulin sensitizers in patients with type 2 diabetes.
Bell DS
Endocr Pract; 2003; 9(1):98-101. PubMed ID: 12917098
[No Abstract] [Full Text] [Related]
10. [Type 2 diabetes. A new kind of insulin sensitizer at the door].
Böhm S
MMW Fortschr Med; 1999 Jul; 141(27):56-7. PubMed ID: 10904588
[No Abstract] [Full Text] [Related]
11. Thiazolidinedione-associated congestive heart failure and pulmonary edema.
Kermani A; Garg A
Mayo Clin Proc; 2003 Sep; 78(9):1088-91. PubMed ID: 12962163
[TBL] [Abstract][Full Text] [Related]
12. [Rosiglitazone (BRL-49653)].
Oka Y
Nihon Rinsho; 2002 Sep; 60 Suppl 9():438-41. PubMed ID: 12387030
[No Abstract] [Full Text] [Related]
13. Troglitazone for non-insulin-dependent diabetes mellitus.
Med Lett Drugs Ther; 1997 May; 39(1001):49-51. PubMed ID: 9164446
[No Abstract] [Full Text] [Related]
14. [Against insulin resistance. Insulin sensitizers].
Verspohl EJ; Weiland F
Pharm Unserer Zeit; 2002; 31(3):280-92. PubMed ID: 12071125
[No Abstract] [Full Text] [Related]
15. [Meta-analysis shows: insulin sensitizer is safe for the liver].
MMW Fortschr Med; 2002 Oct; 144(40):47. PubMed ID: 12440297
[No Abstract] [Full Text] [Related]
16. [Oral therapy in type 2 diabetes. Critical evaluation of glitazones].
Lotz N
MMW Fortschr Med; 2002 Jan; 144(3-4):48-50. PubMed ID: 11862793
[No Abstract] [Full Text] [Related]
17. Insulin action enhancers for the management of type 2 diabetes mellitus.
Valsamakis G; Kumar S
Expert Opin Pharmacother; 2000 Dec; 1(7):1413-21. PubMed ID: 11249474
[TBL] [Abstract][Full Text] [Related]
18. Accelerated hypertension due to rosiglitazone therapy.
Vikram NK; Misra A; Devi JR
Indian Heart J; 2002; 54(6):733. PubMed ID: 12674195
[No Abstract] [Full Text] [Related]
19. [Use of glitazones in type 2 diabetes: a critical position].
Richter B
Dtsch Med Wochenschr; 2001 May; 126(20):606. PubMed ID: 11402929
[No Abstract] [Full Text] [Related]
20. [Clinical efficacy of Pioglitazone (AD-4833)].
Kaneko T; Baba S
Nihon Rinsho; 1997 Nov; 55 Suppl():142-6. PubMed ID: 9434458
[No Abstract] [Full Text] [Related]
[Next] [New Search]